Atrial natriuretic peptide levels in the sleep apnoea/hypopnoea syndrome

Thorax. 1994 Sep;49(9):920-1. doi: 10.1136/thx.49.9.920.

Abstract

Background: Patients with the sleep apnoea/hypopnoea syndrome have increased salt and water excretion at night which has been reported to be associated with an increase in plasma levels of atrial natriuretic peptide (ANP). A study was performed to determine whether any rise in plasma ANP levels was related to nocturnal hypoxaemia.

Methods: Nine patients with sleep apnoea/hypopnoea syndrome were studied on two nights, one breathing air and the other 28% oxygen, the order being randomised. Venous levels of ANP, aldosterone, and renin activity were measured.

Results: No decrease in plasma ANP levels on oxygen was seen, and, indeed, there was no evidence of an overnight increase in ANP levels.

Conclusion: Oxygen therapy does not diminish nocturnal plasma ANP levels in patients with sleep apnoea/hypopnoea syndrome.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Aldosterone / blood
  • Atrial Natriuretic Factor / blood*
  • Humans
  • Male
  • Middle Aged
  • Oxygen Inhalation Therapy*
  • Random Allocation
  • Renin / blood
  • Sleep Apnea Syndromes / blood*
  • Sleep Apnea Syndromes / therapy

Substances

  • Aldosterone
  • Atrial Natriuretic Factor
  • Renin